134 related articles for article (PubMed ID: 32627351)
1. Incidence rate, predictors and outcomes of interruption of HIV care: nationwide results from the Belgian HIV cohort.
Van Beckhoven D; Florence E; De Wit S; Wyndham-Thomas C; Sasse A; Van Oyen H; Macq J;
HIV Med; 2020 Oct; 21(9):557-566. PubMed ID: 32627351
[TBL] [Abstract][Full Text] [Related]
2. A simple self-reported adherence tool as a predictor of viral rebound in people with viral suppression on antiretroviral therapy.
O'Connor JL; Gardner EM; Esser S; Mannheimer SB; Lifson AR; Telzak EE; Phillips AN;
HIV Med; 2016 Feb; 17(2):124-32. PubMed ID: 26186609
[TBL] [Abstract][Full Text] [Related]
3. Linkage and retention in care and the time to HIV viral suppression and viral rebound - New York City.
Robertson M; Laraque F; Mavronicolas H; Braunstein S; Torian L
AIDS Care; 2015; 27(2):260-7. PubMed ID: 25244545
[TBL] [Abstract][Full Text] [Related]
4. Influence of noninjecting and injecting drug use on mortality, retention in the cohort, and antiretroviral therapy, in participants in the Swiss HIV Cohort Study.
Weber R; Huber M; Battegay M; Stähelin C; Castro Batanjer E; Calmy A; Bregenzer A; Bernasconi E; Schoeni-Affolter F; Ledergerber B;
HIV Med; 2015 Mar; 16(3):137-51. PubMed ID: 25124393
[TBL] [Abstract][Full Text] [Related]
5. Determinants of loss to follow-up among HIV positive patients receiving antiretroviral therapy in a test and treat setting: A retrospective cohort study in Masaka, Uganda.
Kiwanuka J; Mukulu Waila J; Muhindo Kahungu M; Kitonsa J; Kiwanuka N
PLoS One; 2020; 15(4):e0217606. PubMed ID: 32255796
[TBL] [Abstract][Full Text] [Related]
6. Use and Outcomes of Antiretroviral Monotherapy and Treatment Interruption in Adolescents With Perinatal HIV Infection in Asia.
Bartlett AW; Lumbiganon P; Kurniati N; Sudjaritruk T; Mohamed TJ; Hansudewechakul R; Ly PS; Truong KH; Puthanakit T; Nguyen LV; Chokephaibulkit K; Do VC; Kumarasamy N; Nik Yusoff NK; Fong MS; Watu DK; Nallusamy R; Sohn AH; Law MG;
J Adolesc Health; 2019 Nov; 65(5):651-659. PubMed ID: 31395514
[TBL] [Abstract][Full Text] [Related]
7. Determinants of virological failure after successful viral load suppression in first-line highly active antiretroviral therapy.
Geretti AM; Smith C; Haberl A; Garcia-Diaz A; Nebbia G; Johnson M; Phillips A; Staszewski S
Antivir Ther; 2008; 13(7):927-36. PubMed ID: 19043927
[TBL] [Abstract][Full Text] [Related]
8. Factors associated with attrition, mortality, and loss to follow up after antiretroviral therapy initiation: data from an HIV cohort study in India.
Alvarez-Uria G; Naik PK; Pakam R; Midde M
Glob Health Action; 2013 Sep; 6():21682. PubMed ID: 24028937
[TBL] [Abstract][Full Text] [Related]
9. Socio-Demographic and Adherence Factors Associated with Viral Load Suppression in HIV-Infected Adults Initiating Therapy in Northern Nigeria: A Randomized Controlled Trial of a Peer Support Intervention.
Coker M; Etiebet MA; Chang H; Awwal G; Jumare J; Musa BM; Babashani M; Habib AG; Dakum P; Abimiku AG; Charurat ME; Blattner WA; Eng M; Ndembi N
Curr HIV Res; 2015; 13(4):279-85. PubMed ID: 25845393
[TBL] [Abstract][Full Text] [Related]
10. Predictors of unstructured antiretroviral treatment interruption and resumption among HIV-positive individuals in Canada.
Samji H; Taha TE; Moore D; Burchell AN; Cescon A; Cooper C; Raboud JM; Klein MB; Loutfy MR; Machouf N; Tsoukas CM; Montaner JS; Hogg RS;
HIV Med; 2015 Feb; 16(2):76-87. PubMed ID: 25174373
[TBL] [Abstract][Full Text] [Related]
11. Contemporary disengagement from antiretroviral therapy in Khayelitsha, South Africa: A cohort study.
Kaplan SR; Oosthuizen C; Stinson K; Little F; Euvrard J; Schomaker M; Osler M; Hilderbrand K; Boulle A; Meintjes G
PLoS Med; 2017 Nov; 14(11):e1002407. PubMed ID: 29112692
[TBL] [Abstract][Full Text] [Related]
12. The effect of a "universal antiretroviral therapy" recommendation on HIV RNA levels among HIV-infected patients entering care with a CD4 count greater than 500/μL in a public health setting.
Geng EH; Hare CB; Kahn JO; Jain V; Van Nunnery T; Christopoulos KA; Deeks SG; Gandhi M; Havlir DV
Clin Infect Dis; 2012 Dec; 55(12):1690-7. PubMed ID: 22955429
[TBL] [Abstract][Full Text] [Related]
13. Temporal association between incident tuberculosis and poor virological outcomes in a South African antiretroviral treatment service.
Gupta-Wright A; Wood R; Bekker LG; Lawn SD
J Acquir Immune Defic Syndr; 2013 Nov; 64(3):261-70. PubMed ID: 23846570
[TBL] [Abstract][Full Text] [Related]
14. Discordant responses on starting highly active antiretroviral therapy: suboptimal CD4 increases despite early viral suppression in the UK Collaborative HIV Cohort (UK CHIC) Study.
Gilson RJ; Man SL; Copas A; Rider A; Forsyth S; Hill T; Bansi L; Porter K; Gazzard B; Orkin C; Pillay D; Schwenk A; Johnson M; Easterbook P; Walsh J; Fisher M; Leen C; Anderson J; Sabin CA;
HIV Med; 2010 Feb; 11(2):152-60. PubMed ID: 19732175
[TBL] [Abstract][Full Text] [Related]
15. Improved long-term antiretroviral treatment outcomes amongst patients receiving community-based adherence support in South Africa.
Fatti G; Mothibi E; Shaikh N; Grimwood A
AIDS Care; 2016 Nov; 28(11):1365-72. PubMed ID: 27251459
[TBL] [Abstract][Full Text] [Related]
16. Does gender or mode of HIV acquisition affect virological response to modern antiretroviral therapy (ART)?
Saunders P; Goodman AL; Smith CJ; Marshall N; O'Connor JL; Lampe FC; Johnson MA
HIV Med; 2016 Jan; 17(1):18-27. PubMed ID: 26140659
[TBL] [Abstract][Full Text] [Related]
17. Substance use patterns and HIV-1 RNA viral load rebound among HIV-positive illicit drug users in a Canadian setting.
Ladak F; Socias E; Nolan S; Dong H; Kerr T; Wood E; Montaner J; Milloy MJ
Antivir Ther; 2019; 24(1):19-25. PubMed ID: 30230474
[TBL] [Abstract][Full Text] [Related]
18. High incidence of intermittent care in HIV-1-infected patients in Curaçao before and after starting cART.
Hermanides HS; Holman R; Gras L; Winkel CN; Gerstenbluth I; de Wolf F; Duits AJ
AIDS Care; 2013; 25(11):1411-7. PubMed ID: 23428308
[TBL] [Abstract][Full Text] [Related]
19. Improved virologic outcomes over time for HIV-infected patients on antiretroviral therapy in a cohort from Rio de Janeiro, 1997-2011.
Martin DA; Luz PM; Lake JE; Clark JL; Veloso VG; Moreira RI; Cardoso SW; Klausner JD; Grinsztejn B
BMC Infect Dis; 2014 Jun; 14():322. PubMed ID: 24919778
[TBL] [Abstract][Full Text] [Related]
20. Treatment interruption and variation in tablet taking behaviour result in viral failure: a case-control study from Cape Town, South Africa.
Ncaca LN; Kranzer K; Orrell C
PLoS One; 2011; 6(8):e23088. PubMed ID: 21858001
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
